Synergistic Cannabidiol Systems for Enhanced Efficacy and Personalized Medicine

The present inventive concept integrates self-emulsifying cannabidiol formulations with advanced technologies such as AI, IoT, blockchain, and new materials to create a powerful system for treating diseases and providing personalized medicine.

The original patent for self-emulsifying cannabidiol formulations provided a significant improvement in bioavailability and stability. However, the patent had limitations in terms of dosage optimization, patient monitoring, and secure data management. The present inventive concept addresses these limitations by incorporating synergistic combinations of technologies to create a more comprehensive and effective system.

The inventive concept comprises a self-emulsifying cannabidiol composition, which is integrated with AI-powered diagnosis tools to optimize dosage based on patient medical history and genetic profile. Additionally, the system incorporates blockchain technology to securely store and track patient medical records and treatment outcomes. Furthermore, IoT sensors are used to monitor cannabidiol levels in the patient's bloodstream and provide real-time feedback. The system also includes a smart packaging system with embedded sensors and blockchain-based tracking to ensure the authenticity and provenance of the composition. Finally, the inventive concept includes a 3D-printed oral delivery system with a built-in IoT sensor to monitor patient compliance and improve bioavailability.

The new claims introduce a novel combination of self-emulsifying cannabidiol formulations with AI, IoT, blockchain, and new materials, providing a synergistic system that is not obvious from the original patent. The inventive concept's novelty lies in its ability to integrate these distinct technologies to provide a more effective and personalized treatment approach.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, IoT sensors, or blockchain platforms. Variations could also include the integration of additional technologies, such as machine learning or robotics, to further enhance the system's capabilities.

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine, disease treatment, and patient monitoring. The system's ability to provide optimized dosage, secure data management, and real-time feedback makes it an attractive solution for healthcare providers and patients alike.